DNA and Gene Chips Market by Type (Oligonucleotide DNA and Complementary DNA), by Product (Consumables and Instruments), by Application (Cancer Diagnosis & Treatment, Gene Expression, Proteomics, Genomics, Drug Discovery, Agricultural Biotechnology, and Others), and by End-User (Academic & Government Research Institutes, Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the DNA and gene chips market on a global and regional level. The study provides historical data for 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the DNA and gene chips market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the DNA and gene chips market on a global level.

In order to give the users of this report a comprehensive view of the DNA and gene chips market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new assay kits launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the DNA and gene chips market on the basis of type, product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.

Some key players of the global DNA and gene chips market are Perkin Elmer, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Macrogen Inc., Agilent Technologies, Greiner Bio-One International GmbH, Asper Biotech, CapitalBio Corporation, Microarrays Inc., Oxford Gene Technology, Arrayit Corporation, and bioMérieux SA.

This report segments the global DNA and gene chips market as follows:

Global DNA and Gene Chips Market: Type Analysis

	Oligonucleotide DNA (o-DNA)
	Complementary DNA (c-DNA)

Global DNA and Gene Chips Market: Product Analysis

	Consumables
	Instruments

Global DNA and Gene Chips Market: Application Analysis

	Cancer Diagnosis and Treatment
	Gene Expression
	Proteomics
	Genomics
	Drug Discovery
	Agricultural Biotechnology
	Others

Global DNA and Gene Chips Market: End-User Analysis

	Academic and Government Research Institutes
	Hospitals and Diagnostics Centers
	Biotechnology and Pharmaceutical Companies
	Others

Global DNA and Gene Chips Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa